Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumors and Hematologic Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03573310
What this trial is testing

JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

Who this might be right for
NeoplasmsSolid Tumor, AdultNon-Hodgkin Lymphoma+1 more
Janssen Research & Development, LLC 114
Early research (Phase 1)Study completedNCT00077155
What this trial is testing

Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+52 more
National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT03886831
What this trial is testing

PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

Who this might be right for
Relapsed/Refractory Advanced Solid TumorsRelapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Myelodysplasia+5 more
Prelude Therapeutics Incorporated 232
Early research (Phase 1)Temporarily pausedNCT03722186
What this trial is testing

Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies

Who this might be right for
Physiological Effects of DrugsNeoplasms by Histologic TypeLymphoma+3 more
Jiangsu HengRui Medicine Co., Ltd. 128
Early research (Phase 1)Ended earlyNCT05607199
What this trial is testing

A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

Who this might be right for
Solid Tumor, AdultAcute Myeloid LeukemiaMyelodysplastic Syndromes+1 more
Aurigene Discovery Technologies Limited 27
Early research (Phase 1)Ended earlyNCT02706392
What this trial is testing

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Lung Non-Small Cell Carcinoma+10 more
Fred Hutchinson Cancer Center 21
Early research (Phase 1)Study completedNCT05694364
What this trial is testing

Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaMantle Cell LymphomaAcute Lymphoblastic Leukemia+2 more
H. Lee Moffitt Cancer Center and Research Institute 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439175
What this trial is testing

Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Looking for participantsNCT05159245
What this trial is testing

The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs

Who this might be right for
Advanced CancerSolid TumorHaematological Malignancy
Helsinki University Central Hospital 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390826
What this trial is testing

Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07749976
What this trial is testing

GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaDiffuse Large B Cell Lymphoma (DLBCL)High Risk Myelodysplastic Syndrome+2 more
Vitruviae 108
Testing effectiveness (Phase 2)Study completedNCT03997968
What this trial is testing

CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Who this might be right for
MalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more
Cyteir Therapeutics, Inc. 169
Not applicableUnknownNCT05099068
What this trial is testing

Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)

Who this might be right for
Advanced / Metastic Solid TumorsGlioblastomaChronic Leukemia Lymphocytic
Centre Leon Berard 500
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04243499
What this trial is testing

First-in-Human Study of ICT01 in Patients With Advanced Cancer

Who this might be right for
Solid Tumor, AdultHematopoietic/Lymphoid Cancer
ImCheck Therapeutics, an Ipsen company 293
Testing effectiveness (Phase 2)Active Not RecruitingNCT02304809
What this trial is testing

Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations

Who this might be right for
Solid TumorsHematologic CancersMetastatic Cancers
UNICANCER 216
Early research (Phase 1)Study completedNCT00769288
What this trial is testing

FAU in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+57 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Ended earlyNCT03422679
What this trial is testing

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Who this might be right for
Breast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more
Cellestia Biotech AG 79
Next Page